Search results for: 'merger and acquisitions deal of 2017'
- Did you mean
- merger and acquisitions deal of 2024
- Related search terms
- Merger and Acquisition Terms and Agreements
- merger+and+acquistions
- Merger and Acquisition Terms and Agreements in Pharma
- merger+and+acquisition
- merger+and+acquisition+deal+and+alliance+of+2014
-
Drug Delivery Collaboration and Licensing Deals 2019-2024November 2024$3,995.00Drug Delivery Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2019 to 2024
Learn More -
Precision Medicine Collaboration and Licensing Deals 2019-2024November 2024$3,995.00Precision Medicine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2019 to 2024
Learn More -
Monoclonal Antibody Collaboration and Licensing Deals 2019-2024May 2024$3,995.00Monoclonal Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
In Vitro Diagnostic Collaboration and Licensing Deals 2016-2024November 2024$3,995.00In Vitro Diagnostic Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Artificial Intelligence (AI) Collaboration and Licensing Deals 2019-2024November 2024$3,995.00Artificial Intelligence (AI) Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2019 to 2024
Learn More -
Cancer Monoclonal Antibody Collaboration and Licensing Deals 2016-2024November 2024$3,995.00Cancer Monoclonal Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Central Nervous System (CNS) Collaboration and Licensing Deals 2019-2024October 2024$3,995.00Central Nervous System (CNS) Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2019 to 2024
Learn More -
Precision Medicine in Oncology Collaboration and Licensing Deals 2016-2024November 2024$3,995.00Precision Medicine in Oncology Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech 2019-2024August 2024$3,995.00The Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech 2019-2024 report provides comprehensive understanding and unprecedented access to the preclinical stage partnering deals and agreements entered into by the worlds leading healthcare companies
Learn More -
Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2019-2024August 2024$3,995.00The Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2019-2024 report provides comprehensive understanding and unprecedented access to the discovery stage partnering agreements entered into by the world's leading biopharma companies.
Learn More
